Andrew G. L. Whitelaw: Difference between revisions
GreenMummets (talk | contribs) No edit summary |
GreenMummets (talk | contribs) No edit summary |
||
| Line 16: | Line 16: | ||
===Hypoxic-Ischaemic Injury in Full-Term Babies=== |
===Hypoxic-Ischaemic Injury in Full-Term Babies=== |
||
Whitelaw's research has involved prevention and treatment of [[Cerebral hypoxia|hypoxic-ischaemic]] injury in full-term newborns. He has been one of the pioneers developing and testing cooling by only a few degrees as a therapeutic approach for neonatal hypoxic-ischaemic [[encephalopathy]]. This intervention (therapeutic hypothermia) has been shown to improve the odds of survival without neurological impairment at 18 months of age.<ref>{{cite web |title=Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic–ischaemic encephalopathy: a nested substudy of a randomised controlled trial |url=https://www.sciencedirect.com/science/article/pii/S1474442209702959 |website=[[Lancet Neurology]] |pages=39–45 |doi=10.1016/S1474-4422(09)70295-9 |date=1 January 2010}}</ref><ref>{{cite web |title=2010: Clinical Science at North Bristol {{!}} News and features {{!}} University of Bristol |url=https://www.bristol.ac.uk/news/2010/6867.html |website=University of Bristol}}</ref><ref>{{cite web |title=Time Course of Brainstem Pathophysiology during First Month in Term Infants after Perinatal Asphyxia, Revealed by MLS BAER Latencies and Intervals |url=https://www.nature.com/articles/pr2003482 |website=[[Pediatric Research]] |pages=680–687 |language=en |doi=10.1203/01.PDR.0000084084.62571.12 |date=November 2003}}</ref> |
Whitelaw's research has involved prevention and treatment of [[Cerebral hypoxia|hypoxic-ischaemic]] injury in full-term newborns. He has been one of the pioneers developing and testing cooling by only a few degrees as a therapeutic approach for neonatal hypoxic-ischaemic [[encephalopathy]]. This intervention (therapeutic hypothermia) has been shown to improve the odds of survival without neurological impairment at 18 months of age.<ref>{{cite web |title=Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic–ischaemic encephalopathy: a nested substudy of a randomised controlled trial |url=https://www.sciencedirect.com/science/article/pii/S1474442209702959 |website=[[Lancet Neurology]] |pages=39–45 |doi=10.1016/S1474-4422(09)70295-9 |date=1 January 2010}}</ref><ref>{{cite web |title=2010: Clinical Science at North Bristol {{!}} News and features {{!}} University of Bristol |url=https://www.bristol.ac.uk/news/2010/6867.html |website=University of Bristol}}</ref><ref>{{cite web |title=Time Course of Brainstem Pathophysiology during First Month in Term Infants after Perinatal Asphyxia, Revealed by MLS BAER Latencies and Intervals |url=https://www.nature.com/articles/pr2003482 |website=[[Pediatric Research]] |pages=680–687 |language=en |doi=10.1203/01.PDR.0000084084.62571.12 |date=November 2003}}</ref> |
||
==Awards== |
|||
* [[Raymond Horton-Smith Prize]] for the best medical thesis of the year (1978). |
|||
* President of the Neonatal Society (2006) |
|||
* Elected member of the [[Norwegian Academy of Science and Letters]] (2016) |
|||
==References== |
==References== |
||
Revision as of 00:45, 10 May 2024
Andrew G. L. Whitelaw (born 31st August, 1946) is a British neonatologist and academic, known for his work on treating conditions affecting newborn babies. He holds the position of Emeritus Professor at Bristol Medical School, associated with Bristol Neuroscience.[1]
He is a member of the Royal College of Physicians and a Fellow of the Royal College of Paediatrics and Child Health. He also served as the president of the Neonatal Society.[2]
His research has over 15,553 citations across 9,919 documents. Additionally, his h-index stands at 61.
Early life
Whitelaw was in West Fife, Scotland to Robert and Cicely Whitelaw.[3]
Whitelaw received early education at Commercial Primary School.[3]
Research
Intraventricular Haemorrhage (IVH) and Hydrocephalus in Premature Babies
One of Whitelaw's notable findings is the efficacy of ventricular lavage in reducing brain injury and disability in post-haemorrhagic hydrocephalus. Ventricular lavage removes toxic substances, such as free iron and pro-inflammatory cytokines, released by old blood.[4][5][6]
Hypoxic-Ischaemic Injury in Full-Term Babies
Whitelaw's research has involved prevention and treatment of hypoxic-ischaemic injury in full-term newborns. He has been one of the pioneers developing and testing cooling by only a few degrees as a therapeutic approach for neonatal hypoxic-ischaemic encephalopathy. This intervention (therapeutic hypothermia) has been shown to improve the odds of survival without neurological impairment at 18 months of age.[7][8][9]
Awards
- Raymond Horton-Smith Prize for the best medical thesis of the year (1978).
- President of the Neonatal Society (2006)
- Elected member of the Norwegian Academy of Science and Letters (2016)
References
- ^ "Professor Andrew Whitelaw". University of Bristol.
- ^ "expert reaction to study looking at paracetamol in pregnancy and behaviour, memory and IQ in children | Science Media Centre". Science Media Centre.
- ^ a b "New book lifts lid on Dunfermline childhood in 1950s". Dunfermline Press. 14 May 2023.
- ^ "Surgical technique for premature babies with brain hemorrhage reduces long-term disability". News-Medical. 6 July 2020.
- ^ "July: DRIFT10-study". University of Bristol.
- ^ "Intraventricular haemorrhage and posthaemorrhagic hydrocephalus: pathogenesis, prevention and future interventions". Seminars in Fetal and Neonatal Medicine.
- ^ "Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic–ischaemic encephalopathy: a nested substudy of a randomised controlled trial". Lancet Neurology. 1 January 2010. pp. 39–45. doi:10.1016/S1474-4422(09)70295-9.
- ^ "2010: Clinical Science at North Bristol | News and features | University of Bristol". University of Bristol.
- ^ "Time Course of Brainstem Pathophysiology during First Month in Term Infants after Perinatal Asphyxia, Revealed by MLS BAER Latencies and Intervals". Pediatric Research. November 2003. pp. 680–687. doi:10.1203/01.PDR.0000084084.62571.12.